Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Jun 6;22(14):4593–4598. doi: 10.1016/j.bmcl.2012.05.103

Table 3.

Apparent bimolecular rate constants ki for inactivation of AgAChE and hAChE by 3-substituted aryl methylcarbamates

Cpd R3 AgAChEa ki (mM−1 min−1) hAChEb ki (mM−1 min−1) Ag/h selectivityc
20h -CH3 17.2 ± 0.3 0.52 ± 0.08 33 ± 5
20i -Pr 881 ± 17 63.7 ± 1.9 14.0 ± 0.5
20j -Bu 741 ± 5 32.1 ± 0.6 23.0 ± 0.5
20k -i-Pr 3,270 ± 70 383 ± 19 8.5 ± 0.5
20l -s-Bu (±) 10,000 ± 100 1,910 ± 110 5.3 ± 0.4
20m -t-Bu 1,510 ± 110 126 ± 3 12 ± 1
20n -CMe2CF3 1,580 ± 40 139 ± 6 11 ± 0.6
20o -CMe2Et 7,600 ± 300 784 ± 28 9.7 ± 0.5
20p -CMe(CF3)Et (±) 3,270 ± 70 375 ± 6 8.7 ± 0.2
20q -CMe2Pr 6,690 ± 240 1,360 ± 40 4.9 ± 0.2
20r -CMeEt2 5,280 ± 170 553 ± 13 9.5 ± 0.4
20s -SiMe3 648 ± 29 67.8 ± 2.6 9.6 ± 0.6
20t -SiMe2Et 1,510 ± 70 110 ± 6 14 ± 1
20u -CH2CHMe2 155 ± 6 5.5 ± 0.30 28 ± 2
20v -OCH2CHEt2 28.8 ± 0.4 5.0 ± 0.6 5.8 ± 0.7
20w -(CH2)2CHMe2 272 ± 10 5.2 ± 2 53 ± 3
a

Recombinant AgAChE purified to 2,500 ± 100 U/mg (Supporting Information).

b

Commercial recombinant hAChE (Sigma C1682).

c

Defined as ki(Ag)/ki (h); error in ratio calculated by standard propagation of error.